SCHEDULE: Vanguard Group Reports 0% Stake in Phibro Animal Health

The Vanguard Group has reported a 0% beneficial ownership in Phibro Animal Health Corp common stock following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 13 to Schedule 13G for Phibro Animal Health Corp, indicating a 0% beneficial ownership of its Common Stock.
• This change stems from an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• As a result of the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. itself no longer has, or is deemed to have, beneficial ownership over securities held by these disaggregated entities.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a procedural update on The Vanguard Group's internal reporting structure rather than a direct positive or negative statement on Phibro Animal Health Corp's prospects.

Positives

• The filing clarifies a change in reporting structure rather than a direct divestment by the entire Vanguard Group, suggesting that underlying investment strategies may continue through other Vanguard-affiliated entities.

Negatives

• The Vanguard Group, as the specific reporting entity, no longer holds any beneficial ownership in Phibro Animal Health Corp, which could be perceived by some investors as a reduction in direct institutional interest from this major fund group.

Risks

• A decrease in reported institutional ownership from a prominent fund group like Vanguard, even if due to internal restructuring, could potentially be misinterpreted by some market participants as a lack of confidence, which might negatively impact market sentiment towards Phibro Animal Health Corp.

Future Outlook

The filing does not provide forward-looking statements or guidance regarding Phibro Animal Health Corp's future performance or The Vanguard Group's future investment intentions beyond the reporting change.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment."
• "Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that internal realignments and changes in reporting structures are common among large asset managers like Vanguard. This specific filing reflects a shift in how Vanguard's various entities report their holdings, rather than a strategic divestment from the animal health sector or Phibro specifically. The actual impact on Phibro's stock would depend on whether the disaggregated entities continue to hold significant stakes.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure for changes in beneficial ownership, aligning with SEC requirements for institutional investors. It does not provide performance metrics for comparison.
• Large asset managers frequently adjust their internal reporting structures, similar to how BlackRock or State Street might reallocate holdings across their various funds or divisions, which then triggers updated Schedule 13G filings.

Stakeholder Impact

• Shareholders of Phibro Animal Health Corp: May observe a change in reported institutional ownership from The Vanguard Group, though the underlying holdings might persist through other Vanguard entities.
• Investment professionals: Will need to monitor subsequent filings from Vanguard's disaggregated entities to understand the full scope of Vanguard's collective holdings in Phibro.

Next Steps

• Other Vanguard subsidiaries or business divisions may file their own Schedule 13G reports detailing their beneficial ownership in Phibro Animal Health Corp, which would provide a clearer picture of Vanguard's collective holdings.

Key Dates

Keywords

Vanguard Group, Phibro Animal Health Corp, Schedule 13G, Beneficial Ownership, Institutional Ownership, Common Stock, SEC Filing, Investment Adviser, Realignment